患有急性不补偿性心力衰竭的患者的药物坚持:急诊室 (ADHF-ED) 的横截面研究

相关实验视频

Updated: Sep 16, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

217

Michael Kunz^1,2,3, Juel Maalouli Schaar⁴, Katharina R Welker³

¹Department of Cardiology, University Heart Center Basel, University Hospital Basel, Basel, Switzerland.

European journal of heart failure

|July 10, 2025

概括

在急性不补偿性心力衰竭 (ADHF) 患者中,不服药是常见的,有助于住院治疗. 客观的毒理学测试对于准确的评估至关重要,因为自我报告不可靠.

科学领域:

心脏病学心脏病学
药理学药理学是指药理学的学科.
临床医学临床医学

背景情况:

不遵守指导方针导向医学治疗 (GDMT) 会对慢性心力衰竭 (CHF) 的结果产生负面影响.
对急性失补性心力衰竭 (ADHF) 患者的药物坚持的客观评估尚未研究.
了解ADHF的坚持模式对于改善患者管理和减少住院治疗至关重要.

研究的目的:

为了评估患者的药物坚持,呈现与ADHF到急诊室.
为了比较客观的 (毒理学分析) 和主观的 (自我报告) 坚持措施.
为了确定与ADHF患者的药物不服药相关的因素.

主要方法:

一项涉及100名ADHF患者的横截面研究.
使用间接 (自我报告) 和直接 (尿液毒理学分析) 方法评估药物坚持.
对人口统计数据,临床特征和药物负担的分析.

主要成果:

只有39%的患者完全遵守基于尿液毒理学的CHF处方药物.
在22%的患者中观察到不坚持 (不检测≥2种药物).
不坚持的患者处方药的数量和药物负担较高;年轻的患者更有可能不坚持. 第三方药物准备与更好的坚持有关. 自己报告的坚持是不准确的.

结论:

在因ADHF住院的患者中,药物坚持率较低.
不遵守是导致CHF和ADHF住院情况恶化的重要因素.
需要有效的工具来评估CHF/ADHF的坚持性,并将毒理学测试作为参考标准.

关键词:

急性失补偿性心力衰竭是什么?坚持的坚持坚持的坚持指南指导的医疗疗法指南指导的医疗疗法.心力衰竭住院治疗心力衰竭住院治疗自我报告自我报告毒理学分析毒理学分析

相关概念视频

01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

01:30

Heart Failure VII: Nursing Interventions

145

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...

145

01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

516

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

516

01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...